Patent · US Active

1,8-naphthyridinone compounds and uses thereof

US10793561B2 · kind B2 · utility

2Cited by

21References

76Claims

0Family size

Assignee

NUVATION BIO INC. · US

Inventors

Son Minh Pham · San Francisco, US
Jiyun Chen · Moraga, US
Amantullah Ansari · Noida, IN
Pradeep S. Jadhavar · Noida, IN
Varshavekumar S. Patil · Greater Noida, IN
Farha Khan · New Delhi, IN
Sreekanth A. Ramachandran · Noida, IN
Anil Kumar Agarwal · Noida, IN
Sarvajit Chakravarty · Sunnyvale, US

Key dates

Filing date	Jul 18, 2018
Grant date	Oct 6, 2020
Priority date	—
Expiry date	Jul 18, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

1,8-naphthyridinone compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.